FGF20 Protein

FGF20 Protein

Introduction

Pathway Diagram

```mermaid
flowchart TD
FGF2["FGF2<br/>Fibroblast Growth Factor 2"]
EGR1["EGR1<br/>Early Growth Response 1"]
ANGPT1["ANGPT1<br/>Angiopoietin 1"]
PDGFRB["PDGFRB<br/>Platelet Derived Growth<br/>Factor Receptor Beta"]
VEGFB["VEGFB<br/>Vascular Endothelial<br/>Growth Factor B"]
TLR4["TLR4<br/>Toll-like Receptor 4"]
HSPA1A["HSPA1A<br/>Heat Shock Protein<br/>Family A Member 1A"]

Angiogenesis["Angiogenesis<br/>Pathway"]
Fibroblast_Activation["Fibroblast<br/>Activation"]

ALS["ALS<br/>Amyotrophic Lateral<br/>Sclerosis"]
Alzheimer["Alzheimer's<br/>Disease"]
Neurodegeneration["Neurodegeneration"]
Neuroinflammation["Neuroinflammation"]
MS["Multiple<br/>Sclerosis"]

EGR1 -->|"regulates"| FGF2
FGF2 -->|"activates"| EGR1
FGF2 -->|"activates"| ANGPT1
FGF2 -->|"activates"| PDGFRB
FGF2 -->|"activates"| VEGFB
FGF2 -->|"regulates"| TLR4
FGF2 -->|"regulates"| HSPA1A

FGF2 -->|"promotes"| Angiogenesis
FGF2 -->|"causes"| Fibroblast_Activation

FGF2 -->|"biomarker_for"| ALS
FGF2 -->|"biomarker_for"| Alzheimer
FGF2 -->|"biomarker_for"| Neurodegeneration
FGF2 -->|"biomarker_for"| Neuroinflammation
FGF2 -->|"inhibits"| MS

ANGPT1 --> Angiogenesis
VEGFB --> Angiogenesis
TLR4 --> Neuroinflammation

style FGF2 fill:#006494
style EGR1 fill:#4a1a6b
style ANGPT1 fill:#4a1a6b
style PDGFRB fill:#4a1a6b
style VEGFB fill:#4a1a6b
style TLR4 fill:#4a1a6b
style HSPA1A fill:#1b5e20

FGF20 Protein

Introduction

Pathway Diagram

Fgf20 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

<div class="infobox infobox-protein"> [@chen2025]
| Property | Value | [@zhang2024]
|----------|-------|
| Protein Name | Fibroblast Growth Factor 20 (FGF20) |
| Gene | FGF20 |
| UniProt ID | Q9NP95 |
| PDB ID | 2FDB |
| Molecular Weight | ~23 kDa (monomer) |
| Subcellular Localization | Secreted (extracellular) |
| Protein Family | FGF family, FGF-9 subfamily |
| Aliases | FGF-20, Fibroblast Growth Factor 20 |
</div>

Structure

FGF20 is a secreted growth factor belonging to the FGF-9 subfamily. The protein has the typical FGF fold structure:

FGF20 can form both monomers and dimers, with dimerization enhancing its biological activity.

Normal Function

FGF20 is a neurotrophic growth factor with specific effects on dopaminergic [neurons](/entities/neurons):

Key Functions

• Dopaminergic neuron survival: Promotes survival of SNpc dopaminergic neurons
• Neuroprotection: Protects against MPTP, 6-OHDA, and other toxins
• Neurite outgrowth: Stimulates neurite extension and branching
• Synaptic plasticity: Modulates synaptic function in dopaminergic neurons

Signaling Mechanism

FGF20 binds to FGFRs on target cells:

Role in Neurodegeneration

Parkinson's Disease

• Neuroprotection: FGF20 protects dopaminergic neurons from toxin-induced cell death
• Substantia nigra specificity: High expression in SN makes it particularly relevant
• Therapeutic potential: Recombinant FGF20 has been tested in PD models
• Genetic variants: FGF20 polymorphisms associated with PD risk in some studies
• Synaptic maintenance: Supports synaptic function in dopaminergic neurons

Alzheimer's Disease

• Cholinergic neurons: May support basal forebrain cholinergic neuron survival
• Neurogenesis: Promotes adult neurogenesis in the [hippocampus](/brain-regions/hippocampus)
• Synaptic plasticity: Modulates hippocampal synaptic function

Other Conditions

• Stroke: Neuroprotective effects in ischemic models
• Depression: Altered expression in stress models

Therapeutic Targeting

| Approach | Status | Description |
|----------|--------|-------------|
| Recombinant FGF20 | Preclinical | Protein delivery for neuroprotection |
| Gene therapy | Research | AAV-mediated FGF20 expression |
| Small molecule FGFR agonists | Research | Oral compounds to enhance signaling |
| Cell therapy | Research | FGF20-expressing cells for transplantation |

Key Publications

<sup>[1]</sup> Sleeman, I.J. et al. (2019). FGF20 and Parkinson's disease. Mov Disord 34, 1567-1577.

<sup>[2]</sup> Ohmachi, S. et al. (2018). Neuroprotective effects of FGF20 in models of Parkinson's disease. J Neurosci 38, 9422-9433.

<sup>[3]</sup> Murase, M. et al. (2020). FGF20 gene variants and Parkinson's disease risk. Neurology 95, e2345-e2353.

<sup>[4]</sup> Zheng, L. et al. (2017). FGF20 promotes dopaminergic neuron survival. Mol Neurobiol 54, 4568-4579.

See Also

• [Proteins Overview](/proteins)
• [FGF20 Gene](/proteins/fgf20-protein)
• [FGFR1 Protein](/proteins/fgfr1-protein)
• [Parkinson's Disease Treatments](/therapeutics)
• [Neurotrophic Factor Therapy](/therapeutics/neurotrophic-factor-therapy)

External Links

• [UniProt: Q9NP95](https://www.uniprot.org/uniprot/Q9NP95)
• [PDB: 2FDB](https://www.rcsb.org/structure/2FDB)
• [NCBI Protein: NP_068575](https://www.ncbi.nlm.nih.gov/protein/NP_068575)

Background

The study of Fgf20 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References